Qatar Investment Authority has invested in the $250 million new financing round of Canadian pharmaceutical startup Kardium, which will facilitate the launch of its latest device to treat heart rhythm ...

A large Framingham Heart Study analysis found that adults with poor cardiovascular health scores on the Life’s Essential 8 ...

Burnaby-based Kardium Inc. announced Wednesday it has raised US$250 million to support the launch of the Globe Pulsed Field ...

Kardium Inc. raised C$340 million (US$250 million) in an oversubscribed financing round to support commercialization of its Globe pulsed field ablation system for atrial fibrillation. Notably, the ...

BC heart device maker Kardium has secured $340 million CAD in financing to fuel the launch of its innovative atrial ...

The funds will support Kardium’s pursuit of regulatory approvals for its Globe pulsed field system ahead of an anticipated ...

The pulsed field ablation developer Kardium has collected $250 million in funding to gear up for the commercial expansion of ...

Cold drink- or food-induced atrial fibrillation/flutter, termed “cold drink heart,” is understudied and underrecognized, but ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

Researchers have successfully 3D printed insulin-producing human pancreas cells that could revolutionize treatment for Type 1 ...

Kardium closed US $250M funding round with Janus Henderson Investors, Qatar Investment Authority, MMCAP, Piper Heartland ...

Company’s device treats atrial fibrillation, a heartbeat disorder that affects more than 59 million people worldwide ...